SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Hims & Hers Health, Inc. (HIMS) (CIK 0001773751) (HIMS) — Jul 15, 2019

Hims & Hers Health, Inc. (HIMS) (CIK 0001773751)
Date: July 15, 2019 · CIK: 0001773751 · Accession: 0001193125-19-194084

AI Filing Summary & Sentiment

File numbers found in text: 333-232444

Date
July 15, 2019
Author
CREDIT SUISSE SECURITIES (USA) LLC
Form
CORRESP
Company
Hims & Hers Health, Inc. (HIMS) (CIK 0001773751)

Letter

Securities and Exchange Commission Division of Corporation Finance Office of Electronics and Machinery Washington, D.C. 20549 Attention: Tim Buchmiller Re: Oaktree Acquisition Corp. (the “Company”) Registration Statement on Form S-1 (Registration No. 333-232444)

Dear Mr. Buchmiller:

In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned hereby joins the request of Oaktree Acquisition Corp. that the effectiveness for the above-captioned Registration Statement on Form S-1 (as amended through the date hereof) filed under the Securities Act be accelerated by the Securities and Exchange Commission (the “Commission”) to 4:00 p.m. Eastern Time, on July 17, 2019, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Kirkland & Ellis LLP, request by telephone that such Registration Statement be declared effective.

Pursuant to Rule 460 under the Act, we wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectus dated July 15, 2019:

(i) Dates of distribution: July 15, 2019 through the date hereof

(ii) Number of prospective underwriters to which the preliminary prospectus was furnished: 2

(iii) Number of prospectuses furnished to underwriters, dealers, institutions and others: approximately 1,050

We, the undersigned, as representative of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

[Signature Page Follows]

Very truly yours,
CREDIT SUISSE SECURITIES (USA) LLC

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 Credit Suisse Securities (USA) LLC

11 Madison Ave.

 New York, New York 10010

Deutsche Bank Securities Inc.

60 Wall Street

 New York, New York 10005

July 15, 2019

 VIA EMAIL &
EDGAR

 Securities and Exchange Commission

 Division of
Corporation Finance

 Office of Electronics and Machinery

 100
F Street, N.E.

 Washington, D.C. 20549

 Attention: Tim
Buchmiller

Re:
 Oaktree Acquisition Corp. (the “Company”)

Registration Statement on Form S-1 (Registration
No. 333-232444)

 Dear Mr. Buchmiller:

In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned
hereby joins the request of Oaktree Acquisition Corp. that the effectiveness for the above-captioned Registration Statement on Form S-1 (as amended through the date hereof) filed under the Securities Act be
accelerated by the Securities and Exchange Commission (the “Commission”) to 4:00 p.m. Eastern Time, on July 17, 2019, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Kirkland &
Ellis LLP, request by telephone that such Registration Statement be declared effective.

 Pursuant to Rule 460 under the Act, we wish to advise you that we
have effected the following distribution of the Company’s Preliminary Prospectus dated July 15, 2019:

(i)
 Dates of distribution: July 15, 2019 through the date hereof

(ii)
 Number of prospective underwriters to which the preliminary prospectus was furnished: 2

(iii)
 Number of prospectuses furnished to underwriters, dealers, institutions and others: approximately 1,050

 We, the undersigned, as representative of the several underwriters, have complied and will comply, and we have been informed by the
participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

[Signature Page Follows]

 Very truly yours,

CREDIT SUISSE SECURITIES (USA) LLC

 Credit Suisse Securities
(USA) LLC

By:

 /s/ Stefanie Gallagher

Name: Stefanie Gallagher

Title:   Managing Director

 DEUTSCHE BANK SECURITIES INC.

Deutsche Bank Securities Inc.

By:

 /s/ Jack Rabun

Name: Jack Rabun

Title:   Managing Director

By:

 /s/ Bruce Harting

Name: Bruce Harting

Title:   Managing Director

 [Signature Page to Acceleration Request Letter]